| Mr Philip Leonard Riccobono, LCSW, LTD | |
|
2740 S Jones Blvd, Las Vegas, NV 89146-5306 | |
| (702) 515-3670 | |
| (702) 248-1339 |
| Full Name | Mr Philip Leonard Riccobono |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 2740 S Jones Blvd, Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174556328 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 01246 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Philip Leonard Riccobono, LCSW, LTD 2740 S Jones Blvd, Las Vegas, NV 89146-5306 Ph: (702) 515-3670 | Mr Philip Leonard Riccobono, LCSW, LTD 2740 S Jones Blvd, Las Vegas, NV 89146-5306 Ph: (702) 515-3670 |
News Archive
Real-world study findings from France show the significant impact tyrosine kinase inhibitor treatment has had on the survival of patients with Philadelphia chromosome-positive chronic myeloid leukaemia.
A new analysis of COVID-19 outbreaks in 58 cities has found that places that took longer to begin implementing social distancing measures spent more time with the virus rapidly spreading than others that acted more quickly.
Purdue Pharma L.P. announced today that Intermezzo (zolpidem tartrate) sublingual tablet CIV is now available in 1.75 mg and 3.5 mg dosage strengths by prescription in retail pharmacies nationwide.
A review of previous studies suggests that even though atypical antipsychotic medications are commonly used for off-label conditions such as behavioral symptoms of dementia, anxiety, and obsessive-compulsive disorder, these medications are effective for only a few off-label conditions, and that the benefits and harms of these medications for these uses vary, according to an article in the September 28 issue of JAMA.
Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN™ (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission includes the results of two pivotal Phase 3 clinical trials showing that 900-mcg albinterferon alfa-2b dosed every two weeks met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) dosed once each week.
› Verified 5 days ago
Mrs. Marysol Rezanov, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 4170 S Decatur Blvd Ste C1, Las Vegas, NV 89103 Phone: 702-659-8827 Fax: 702-852-0984 | |
Arthur Tabrizi, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6543 Las Vegas Blvd S Unit 200, Las Vegas, NV 89119 Phone: 702-933-9535 | |
Mr. David Alexander Sturgeon, CSW-INTERN Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7381 Prairie Falcon Rd, Las Vegas, NV 89128 Phone: 702-468-1321 Fax: 702-396-0015 | |
Mrs. Pamela Rinato, LCSW, PSYD Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3371 N Buffalo Drive, Las Vegas, NV 89129 Phone: 702-515-1374 Fax: 702-331-3098 | |
Latoyia Kurbane Griffin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3375 S Rainbow Blvd Unit 82251, Las Vegas, NV 89180 Phone: 702-485-0430 | |
Mr. Gerald R Earl, MSSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3131 La Canada St Ste 216, Las Vegas, NV 89109 Phone: 702-636-3000 | |
Dr. Barbara Bassong, PHD, MS, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4700 Las Vegas Blvd N, Las Vegas, NV 89191 Phone: 702-653-2422 |